S. USLU Et Al. , "The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort.," 2022 ACR/ARHP Annual Meeting , vol.74, PHİLADELPHİA, United States Of America, pp.847-849, 2022
USLU, S. Et Al. 2022. The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort.. 2022 ACR/ARHP Annual Meeting , (PHİLADELPHİA, United States Of America), 847-849.
USLU, S., GÜLLE, S., CAN, G., ŞENEL, S., ÇAPAR, S., DALKILIÇ, H. E., ... AKAR, S.(2022). The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort. . 2022 ACR/ARHP Annual Meeting (pp.847-849). PHİLADELPHİA, United States Of America
USLU, SADETTİN Et Al. "The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort.," 2022 ACR/ARHP Annual Meeting, PHİLADELPHİA, United States Of America, 2022
USLU, SADETTİN Et Al. "The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort.." 2022 ACR/ARHP Annual Meeting , PHİLADELPHİA, United States Of America, pp.847-849, 2022
USLU, S. Et Al. (2022) . "The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort.." 2022 ACR/ARHP Annual Meeting , PHİLADELPHİA, United States Of America, pp.847-849.
@conferencepaper{conferencepaper, author={SADETTİN USLU Et Al. }, title={The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort.}, congress name={2022 ACR/ARHP Annual Meeting}, city={PHİLADELPHİA}, country={United States Of America}, year={2022}, pages={847-849} }